YU16893A - Derivati diarilsulfonamida i postupak za njihovo dobijanje - Google Patents

Derivati diarilsulfonamida i postupak za njihovo dobijanje

Info

Publication number
YU16893A
YU16893A YU16893A YU16893A YU16893A YU 16893 A YU16893 A YU 16893A YU 16893 A YU16893 A YU 16893A YU 16893 A YU16893 A YU 16893A YU 16893 A YU16893 A YU 16893A
Authority
YU
Yugoslavia
Prior art keywords
derivatives
diarylsulphonamide
procedure
production
halo
Prior art date
Application number
YU16893A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
F. Mohamadi
M.M. Spees
Original Assignee
Eli Lilly And Company Indianapolis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company Indianapolis filed Critical Eli Lilly And Company Indianapolis
Publication of YU16893A publication Critical patent/YU16893A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
YU16893A 1992-03-13 1993-03-11 Derivati diarilsulfonamida i postupak za njihovo dobijanje YU16893A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/850,531 US5169860A (en) 1992-03-13 1992-03-13 Antitumor compositions and methods of treatment

Publications (1)

Publication Number Publication Date
YU16893A true YU16893A (sh) 1996-07-24

Family

ID=25308394

Family Applications (1)

Application Number Title Priority Date Filing Date
YU16893A YU16893A (sh) 1992-03-13 1993-03-11 Derivati diarilsulfonamida i postupak za njihovo dobijanje

Country Status (19)

Country Link
US (1) US5169860A (cg-RX-API-DMAC7.html)
EP (1) EP0560554A2 (cg-RX-API-DMAC7.html)
JP (1) JPH0649052A (cg-RX-API-DMAC7.html)
KR (1) KR930019655A (cg-RX-API-DMAC7.html)
CN (1) CN1076447A (cg-RX-API-DMAC7.html)
AU (2) AU662605B2 (cg-RX-API-DMAC7.html)
BR (1) BR9301137A (cg-RX-API-DMAC7.html)
CA (1) CA2091207A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ36893A3 (cg-RX-API-DMAC7.html)
FI (1) FI931085A7 (cg-RX-API-DMAC7.html)
HU (1) HUT63830A (cg-RX-API-DMAC7.html)
IL (1) IL104981A0 (cg-RX-API-DMAC7.html)
MX (1) MX9301296A (cg-RX-API-DMAC7.html)
MY (1) MY111178A (cg-RX-API-DMAC7.html)
NO (1) NO930891L (cg-RX-API-DMAC7.html)
NZ (1) NZ247083A (cg-RX-API-DMAC7.html)
TW (1) TW215083B (cg-RX-API-DMAC7.html)
YU (1) YU16893A (cg-RX-API-DMAC7.html)
ZA (1) ZA931645B (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
CO4410190A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US5863936A (en) * 1995-04-18 1999-01-26 Geron Corporation Telomerase inhibitors
AU5258696A (en) * 1996-03-19 1997-10-10 Eli Lilly And Company Synthesis of 3-{4-(2-aminoethoxy)-benzoyl}-2-aryl-6-hydroxy-benzo{b}thiop henes
JP3226100B2 (ja) * 1996-08-22 2001-11-05 同和薬品工業株式會社 抗腫瘍剤としてのアリールスルホニルイミダゾロン誘導体
EP0929540A4 (en) * 1996-10-04 2001-12-12 Lilly Co Eli ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS
JP2000247949A (ja) * 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
JP4505876B2 (ja) * 1999-05-25 2010-07-21 東ソー株式会社 ４−ハロベンゾフラン誘導体及びその製造方法
TWI281916B (en) * 2001-10-25 2007-06-01 Lilly Co Eli Antitumor compounds and methods
US20050119318A1 (en) * 2003-10-31 2005-06-02 Hudyma Thomas W. Inhibitors of HCV replication
WO2009070744A1 (en) * 2007-11-28 2009-06-04 Sequoia Pharmaceuticals, Inc. Compositions and methods for inhibiting cytochrome p450 2d6
KR101300702B1 (ko) * 2011-01-20 2013-08-26 대우조선해양 주식회사 탈가스 장치
CN103450149B (zh) * 2012-06-01 2015-10-14 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物及其制备方法和用途
CN104564805B (zh) * 2013-10-29 2017-11-10 海尔集团公司 一种离心风机的扇叶结构、离心风机及嵌入式空调内机
ME03737B (me) * 2015-02-16 2021-01-20 Univ Queensland Sulfoniluree i srodna jedinjenja i njihova upotreba
WO2017184624A1 (en) 2016-04-18 2017-10-26 Ifm Therapeutics, Inc Compounds and compositions for treating conditions associated with nlrp activity
BR112020000259A2 (pt) 2017-07-07 2020-07-14 Inflazome Limited novos compostos de sulfonamida-carboxamida
MX2020000911A (es) 2017-07-24 2020-09-10 Novartis Ag Star Compuestos y composiciones para tratar afecciones asociadas con la actividad nlrp.
US11926600B2 (en) 2017-08-15 2024-03-12 Inflazome Limited Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
EP3668842A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors
PE20200758A1 (es) 2017-08-15 2020-07-27 Inflazome Ltd Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3
PE20210050A1 (es) 2017-11-09 2021-01-08 Inflazome Ltd Nuevos compuestos de sulfonamida carboxamida
WO2019092171A1 (en) 2017-11-09 2019-05-16 Inflazome Limited Novel sulfonamide carboxamide compounds
EP3759077A1 (en) 2018-03-02 2021-01-06 Inflazome Limited Novel compounds
JP2022505525A (ja) * 2018-10-24 2022-01-14 ノバルティス アーゲー Ｎｌｒｐ活性に関連する状態を治療するための化合物及び組成物
CN109384764B (zh) * 2018-12-12 2021-09-03 中国科学院上海有机化学研究所 苯基噻吩磺酰胺类化合物、药物组合物、其制备方法和应用
WO2022022646A1 (zh) * 2020-07-29 2022-02-03 南京明德新药研发有限公司 含硒五元杂芳环化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
GB1050447A (cg-RX-API-DMAC7.html) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
IL69621A0 (en) * 1982-09-02 1983-12-30 Duphar Int Res Pharmaceutical compositions having antitumor activity,comprising certain phenylurea derivatives
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
GR862353B (en) * 1985-09-23 1987-01-19 Lilly Co Eli Anti-tumor method and compounds
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU9300688D0 (en) 1993-05-28
EP0560554A3 (cg-RX-API-DMAC7.html) 1994-01-19
IL104981A0 (en) 1993-07-08
NZ247083A (en) 1995-09-26
CA2091207A1 (en) 1993-09-14
CZ36893A3 (en) 1994-04-13
NO930891L (no) 1993-09-14
MY111178A (en) 1999-09-30
FI931085A0 (fi) 1993-03-11
AU3519893A (en) 1993-09-16
JPH0649052A (ja) 1994-02-22
CN1076447A (zh) 1993-09-22
BR9301137A (pt) 1993-09-28
AU4028995A (en) 1996-02-15
HUT63830A (en) 1993-10-28
FI931085L (fi) 1993-09-14
ZA931645B (en) 1994-09-08
MX9301296A (es) 1993-10-01
US5169860A (en) 1992-12-08
TW215083B (cg-RX-API-DMAC7.html) 1993-10-21
AU662605B2 (en) 1995-09-07
EP0560554A2 (en) 1993-09-15
KR930019655A (ko) 1993-10-18
NO930891D0 (no) 1993-03-11
FI931085A7 (fi) 1993-09-14

Similar Documents

Publication Publication Date Title
YU16893A (sh) Derivati diarilsulfonamida i postupak za njihovo dobijanje
YU48105B (sh) Derivati triazola i postupak za njihovo dobijanje
YU17092A (sh) Derivati 2,4-diaminohinazolina
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
YU30492A (sh) Derivati piperidina i postupci za njihovo dobijanje
NO159795C (no) Fremgangsmaate for fremstilling av 2-penemforbindelser.
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
ES8203845A1 (es) Procedimiento para preparar derivados de piridoxina
AU6747687A (en) New derivatives of decahydroquinoline,their preparation process, the preparation intermediates, their use as medicaments and the compositions containing them
ES2068413T3 (es) Derivados de 4-fenilftalazina.
PT87578A (pt) Process for the preparation of new alkanesulfonanilide derivatives and of pharmaceutical composition comprising the same
IL67812A (en) Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
YU142791A (sh) Heterociklična jedinjenja
ZA854005B (en) Penem derivatives
ES8107206A1 (es) Procedimiento para obtener derivados de tiazol
PT90815A (pt) Processo de preparacao de derivados da fenotiazina
MY105057A (en) A process for preparing naphthalene derivatives
YU12191A (sh) Kristalni hidrohlorid novog beta-laktamskog antibiotika i postupak za njegovo dobijanje
DK428087A (da) Dihydropyridin-5-phosphonsyre-cyclopropylenester
DK168284D0 (da) Troponderivater
PH18574A (en) Substituted 11-oxo-11h-pyrido 2,i-h -quinazoline derivatives,pharmaceutical compositions containing them and method of use thereof